On Friday, New Zealand's S&P/NZX 50 index ended the day down 0.8% at 13,467, primarily impacted by declines in health tech stocks. Notably, the medical device manufacturer Fisher & Paykel Healthcare experienced a 3.5% drop. Additionally, pharmaceutical supplier Ebos Group and cancer diagnostics firm Pacific Edge saw decreases of 0.4% and 2.0%, respectively. The aged care sector also faced challenges, with Ryman Healthcare's shares falling 0.7% and Oceania Healthcare's shares down 2.0%. Other companies among the significant decliners included Infratil, which dropped 1.0%, Fletcher Building with a decrease of 1.8%, and Air New Zealand, which slipped 1.65%. Investor sentiment was further dampened by setbacks on Wall Street, as efforts to resolve the US government shutdown stalled after funding proposals failed to advance in the Senate for the seventh time on Thursday. Over the course of the week, the NZX 50 index declined by 0.35%.